AI Hallucinations: What Are They and Are They Always Bad?
AI hallucinations may not always be bad, according to a panel of experts at the MedCity INVEST Digital Health conference. Instead, they may let people know when there are gaps in the data.
Survey: A third of states weighing moves to spend less on drugs
States are trying to strengthen their hand over drug prices in light of stalled federal efforts and their own budget crunches. The wildcard is whether the efforts will survive legal scrutiny.
presented by
Esperion Sets Its Sights on New Areas While Maintaining Commitment to Cardiovascular Health
In a recent interview, Esperion president and CEO, Sheldon Koenig talks about the reality of statin intolerance and his company’s expansion into new diseases
For insurers, rising unemployment a more pressing concern than Covid-19 costs
As insurers set premium rates for next year, many are working through the complicated math of how much Covid-19 will actually cost. It’s too early to say at this point, but these companies face another concern: how many Americans will lose their insurance if unemployment rates continue to rise?
How do we get more women into boardroom and leadership roles?
As part of the second annual HLTH conference October 27-30 at the MGM Grand in Las Vegas will be a set of programming focused on how to get more women into the boardroom and leadership roles in healthcare and life sciences.